¹ú¼ÒÁ¢ÒìÐÍÆóÒµ¡¢ºãÖ¸Ê×¼ÒÒ½Ò©³É·Ý¹É
ʯҩ¿Ø¹É¼¯ÍÅÓÐÏÞ¹«Ë¾
ʯҩ¿Ø¹É¼¯ÍÅÓÐÏÞ¹«Ë¾ÊÇÒ»¼Ò¼¯Á¢ÒìÒ©ÎïÑз¢¡¢Éú²úºÍÏúÊÛΪһÌåµÄ¹ú¼ÒÁ¢ÒìÐÍÆóÒµ¡£¡£¡£¡£¡£¡£È«¼¯ÍÅÏÖÓÐ×ʲú×ܶî786ÒÚÔª£¬£¬£¬£¬£¬Ô±¹¤2.8ÍòÈË¡£¡£¡£¡£¡£¡£¼¯ÍÅÔÚ¸Û¹ÉÓëA¹É¾ùÓÐÒ»¼ÒÉÏÊй«Ë¾£¬£¬£¬£¬£¬ÔÚ¸ÛÉÏÊй«Ë¾£¨01093.HK£©ÊǺãÉúÖ¸Êý³É·Ý¹É¡£¡£¡£¡£¡£¡£
-
10+
Ò©Æ·Éú²ú»ùµØ
-
110++
²úÆ·ÏúÊÛ¹ú¼Ò»òµØÇø
-
300+
ÔÚÑвúÆ·ÏîÄ¿
-
2026-02-25
°²¸´Àû¿Ë?ÖÎÁÆÃ«Ã¹¾ú²¡ÁÆÐ§ÓëÇå¾²ÐÔµÄÒ»ÏîÕæÊµÌìÏÂÑо¿Ð§¹û
½üÆÚ£¬£¬£¬£¬£¬¸´µ©´óѧÁ¥ÊôÎ÷ÔÀÒ½ÔºÖìÀûƽ½ÌÊÚÔÚ¹ú¼ÊÆÚ¿¯¡¶BMC Infectious Diseases¡·½ÒÏþÁËÌâΪ¡°Efficacy and safety of amphotericin B colloidal dispersion in the treatment of mucormycosis: a real-world observation¡±µÄÕæÊµÌìÏÂÑо¿£¬£¬£¬£¬£¬¸ÃÑо¿ÆÀ¹ÀÁËÁ½ÐÔÃ¹ËØBµ¨¹Ì´¼ÁòËáõ¥¸´ºÏÎABCD£¬£¬£¬£¬£¬ÉÌÆ·Ãû£º°²¸´Àû¿Ë?£©ÖÎÁÆÃ«Ã¹¾ú²¡µÄÁÆÐ§ÓëÇå¾²ÐÔ£¬£¬£¬£¬£¬ÎªÁÙ´²ÌṩÁËеÄÓÐÁ¦Ö¤¾Ý¡£¡£¡£¡£¡£¡£
-
2026-02-11
ʯҩ¼¯ÍÅÒ»ÏîÁ¢ÒìÒ©Ñо¿Ð§¹ûÈëÑ¡2026ÄêÅ·Ö޷ΰ©´ó»á(ELCC)
3ÔÂ25ÈÕÖÁ28ÈÕ£¬£¬£¬£¬£¬Å·Ö޷ΰ©´ó»á£¨ELCC£©½«ÔÚµ¤Âó¸ç±¾¹þ¸ù¾ÙÐÐÕÙ¿ª¡£¡£¡£¡£¡£¡£Ê¯Ò©¼¯ÍÅÔÚ±¾½ìÅ·Ö޷ΰ©´ó»áÉϽ«Õ¹Ê¾Ò»ÏîÁ¢ÒìÒ©µÄ×îÐÂÁÙ´²Ñо¿Ï£Íû¡£¡£¡£¡£¡£¡£
-
2026-02-05
ºÓ±±Ê¡Ê¯Ò©ÆÕ¶÷´ÈÉÆ»ù½ð»áÈÙ»ñ¡°ÌìÏÂÏȽøÉç»á×éÖ¯¡±³Æºô
2ÔÂ2ÈÕÉÏÎ磬£¬£¬£¬£¬¹ú¼ÒÃñÕþ²¿ÕÙ¿ªµÚÎå´Î¡°ÌìÏÂÏȽøÉç»á×éÖ¯¡±±íÑï´ó»á£¬£¬£¬£¬£¬ºÓ±±Ê¡Ê¯Ò©ÆÕ¶÷´ÈÉÆ»ù½ð»á×÷Ϊ»ñ½±µ¥Î»²Î»á²¢Áì½±¡£¡£¡£¡£¡£¡£
Social welfare
Éç»á¹«Òæ
ÖúÈËÖú¼º£¬£¬£¬£¬£¬ÐÄ»³¸Ð¶÷£»£»£»£»£»£»£»£»Ê÷ÈËÊ÷ľ£¬£¬£¬£¬£¬ÉƱ¨ÌìÏÂ


.jpg)
.jpg)





















